Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro

Peptides

Volumn 20, Issue 7, 1999, Pages 843-850

  Csernus, Valér ^a,b   Schally, Andrew V ^a,b   Groot, Kate ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cAMP release; Growth hormone releasing hormone; Human cancer cells; In vitro superfusion; Pituitary adenylate cyclase activating peptide; Vasoactive intestinal peptide

Indexed keywords

CYCLIC AMP; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; SERMORELIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CYCLIC AMP; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; NEOPLASMS; PANCREATIC NEOPLASMS; PITUITARY GLAND, ANTERIOR; PROSTATIC NEOPLASMS; RATS; SECOND MESSENGER SYSTEMS; SERMORELIN; TUMOR CELLS, CULTURED; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032767246     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00071-6     Document Type: Article

References (35)

1. Bagnato A., Moretti C., Ohnishi J., Frajese G., Catt K.J. Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary. Endocrinology. 130:1992;1097-1102.
2. Cho-Chung Y.S., Clair T., Bodwin J.S., Berghoffer B. Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine. Science. 214:1981;77-79.
3. Ciampani T., Fabbri A., Isidori A., Dufau M.L. Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function. Endocrinology. 131:1992;2785-2792.
4. Cohran V., Fang J., Milio L., Smith C.H., Fant M. Type I insulin-like growth factor receptors in the BeWo choriocarcinoma cell (b30 clone) during cell differentiation. Placenta. 17:1996;313-320.
5. Csernus V.J., Schally A.V. The dispersed cell superfusion system. Grenstein B.D. Neuroendocrine research methods. 1991;71-109 Harwood Academic Publishers, London.
6. Csernus V.J., Schally A.V., Kiaris H., Armatis P. Inhibition of growth, production of insulin-like growth factor-II (IGF), and expression of IGF-II mRNA of human cancer cell-lines by antagonistic analogs of growth hormone-releasing hormone in vitro. Proc Natl Acad Sci USA. 96:1999;3098-3103.
7. Daughaday W.H. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology. 127:1990;1-4.
8. Figueroa J.A., Lee A.V., Jackson J.G., Yee D. Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1 evidence for an IGF-II autocrine growth loop . J Clin Endocrinol Metab. 80:1995;3476-3482.
9. Frohman L.A., Thominet J.L., Szabo M. Ectopic growth hormone-releasing factor syndromes. Raiti S., Tolman R.A. Human growth hormone. 1986;347-360 Plenum Medical Book Co, New York.
10. Frohman L.A., Downs T.R., Chomczynski P., Brar A., Kashio Y. Regulation of growth hormone-releasing hormone gene expression and biosynthesis. Yale J Biol Med. 62:1989;427-433.
11. Frohman L.A., Downs T.R., Heimer E.P., Felix A.M. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. J Clin Invest. 83:1989;1533-1540.
12. Gaylinn B.D., Harrison J.K., Zysk J.R., Lyons C.E., Lynch K.R., Thorner M.O. Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol Endocrinol. 7:1993;77-84.
13. Horváth J.E., Groot K., Schally A.V. Growth hormone-releasing hormone stimulates cAMP release in superfused rat pituitary cells. Proc Natl Acad Sci USA. 92:1995;1856-1860.
14. Horváth J.E., Zarándi M., Groot K., Schally A.V. Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3′,5′-monophosphate release in superfused rat pituitary cells. Endocrinology. 136:1995;3849-3855.
15. Ip C., Dao T.L. Regulation of cyclic adenosine 3′,5′-monophosphate in relation to growth of dimethylbenz[a]anthracene-induced mammary tumors in rats. Cancer Lett. 8:1980;227-233.
16. Jungwirth A., Schally A.V., Pinski J., Groot K., Armatis P., Halmos G. Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of CAKI-I renal adenocarcinoma. Proc Natl Acad Sci USA. 94:1997;5810-5813.
17. Jungwirth A., Schally A.V., Pinski J., Halmos G., Groot K., Armatis P., Vadillo-Buenfil M. Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone (GH-RH). Br J Cancer. 75:1996;1585-1592.
18. Kahán Z., Arencibia J.M., Csernus V.J., Groot K., Kineman R.D., Robinson W.R., Schally A.V. Expression of growth hormone releasing- hormone (GHRH) mRNA and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J Clin Endocrinol Metab. 84:1999;582-589.
19. Kassem M., Okazaki R., Harris S.A., Spelsberg T.C., Conover C.A., Riggs B.L. Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int. 62:1998;60-66.
20. Laburthe M., Couvineau A., Gaudin P., Maoret J.J., Rouyer-Fessard C., Nicole P. Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors structure-function relationship with special reference to the human VIP-1 receptor . Ann NY Acad Sci USA. 805:1996;94-109.
21. Lamharzi N., Schally A.V., Koppán M., Groot K. Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors. Proc Natl Acad Sci USA. 95:1998;8864-8868.
22. Lee M., Jensen R.T., Huang S.C., Bepler G., Korman L., Moody T.W. Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levels. Peptides. 11:1990;1205-1209.
23. Macaulay V.M. Insulin-like growth factors and cancer. Br J Cancer. 65:1992;311-320.
24. Martin T.J., Hunt N.H., Boyd H., Ellison M., Michelangeli V.P., Atkins D. Hormone receptors and cyclic nucleotide metabolism in cancer cells. Clin Endocrinol (Oxf). 5:(suppl.):1976;373S-386S.
25. Nelson R.L., Holian O. Adenylate cyclase activity and cyclic adenosine monophosphate levels in colon cancer lines and dermal fibroblasts and the effects of cholera toxin and epidermal growth factor. J Surg Oncol. 38:1988;108-112.
26. Pinski J., Schally A.V., Groot K., Halmos G., Szepeshazi K., Zarándi M., Armatis P. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone (GH-RH). J Natl Cancer Inst. 87:1995;1787-1794.
27. Pinski J., Schally A.V., Jungwirth A., Groot K., Halmos G., Armatis P., Zarándi M., Vadillo-Buenfil M. Inhibition of growth of human small-cell and non-small-cell lung carcinomas by antagonists of growth hormone-releasing hormone (GH-RH). Int J Oncol. 9:1996;1099-1105.
28. Plotsky P.M., Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science. 230:1985;461-463.
29. Rékási Z., Sule N., Csernus V., Mess B. Adrenergic and peptidergic control of the regulation of cAMP efflux and melatonin secretion from perfused rat pineal gland. Endocrine. 9:1998;89-96.
30. Schally A.V., Kovács M., Toth K., Comaru-Schally A.M. Antagonistic analogs of growth hormone-releasing hormone (GH-RH) endocrine and oncological studies . Bercu B.B., Walker R.F. Growth hormone secretagogues in clinical practice. 1998;145-162 Marcel Dekker, New York.
31. Shibasaki T., Kiyosawa Y., Masuda A., Nakahara M., Imaki T., Wakabayashi I., Demura H., Shizume K., Ling N. Distribution of growth hormone-releasing hormone-like immunoreactivity in human tissue extracts. J Clin Endocrinol Metab. 59:1984;263-268.
32. Toretsky J.A., Helman L.J. Involvement of IGF-II in human cancer. J Endocrinol. 149:1996;367-372.
33. Westley B.R., May F.E.B. Insulin-like growth factors the unrecognized oncogenes . Br J Cancer. 72:1995;1065-1066.
34. Zarándi M., Horváth J.E., Halmos G., Pinski J., Nagy A., Groot K., Rékási Z., Schally A.V. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci USA. 91:1994;12298-12302.
35. Zarándi M., Kovács M., Horváth J., Toth K., Halmos G., Groot K., Nagy A., Kele Z., Schally A.V. Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GH-RH). Peptides. 18:1997;423-430.